Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | GRO-a | 19845.0 | 84 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | GRO-a | 7082.0 | 69 | |
RA2159 | PI103 | 0.1 | uM | 3 | GRO-a | 6065.5 | 84 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 3 | GRO-a | 20768.5 | 82 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | GRO-a | 18385.0 | 73 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | GRO-a | 20198.0 | 50 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | GRO-a | 19514.0 | 64 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | GRO-a | 15511.0 | 59 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | GRO-a | 18122.5 | 74 | |
N2586 | PI103 | 0.1 | uM | 3 | GRO-a | 6818.5 | 64 | ||||
0 | GRO-a | 65.0 | 68 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 3 | GRO-a | 15052.0 | 59 | ||||
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | GRO-a | 14310.0 | 69 | |
RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | GRO-a | 11612.0 | 69 | |
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | GRO-a | 14832.0 | 46 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | GRO-a | 14140.0 | 51 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | GRO-a | 7681.0 | 63 | |
RA2159 | EO1428 | 1.0 | uM | 3 | GRO-a | 5954.5 | 28 | ||||
N2586 | TNF-a | 100 | ng/mL | 3 | GRO-a | 16537.0 | 63 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | GRO-a | 14768.0 | 69 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | GRO-a | 16474.0 | 78 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | GRO-a | 16362.0 | 75 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | GRO-a | 5268.5 | 64 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | GRO-a | 14876.5 | 78 | |
N2586 | EO1428 | 1.0 | uM | 3 | GRO-a | 9337.5 | 68 |